KENNETH MCLEISH, MD
Osteopathic Medicine at Preston St, Louisville, KY

License number
Kentucky 21143
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
615 S Preston St, Louisville, KY 40202
Phone
(502) 852-5757
(502) 852-7643 (Fax)
(502) 589-4856
(502) 589-5093 (Fax)

Personal information

See more information about KENNETH MCLEISH at radaris.com
Name
Address
Phone
Kenneth Mcleish, age 77
2412 Douglass Blvd, Louisville, KY 40205
(502) 457-0366
Kenneth R Mcleish, age 77
2178 Park Boundary Rd, Louisville, KY 40205
(502) 451-0366
Kenneth R Mcleish
615 Preston St, Louisville, KY 40202
(502) 852-5757
Kenneth R Mcleish
401 Chestnut St, Louisville, KY 40202
(502) 852-5757
Kenneth R Mcleish
400 Market St, Louisville, KY 40202
(502) 852-5757

Organization information

See more information about KENNETH MCLEISH at bizstanding.com

Kenneth McLeish MD

615 S Preston St, Louisville, KY 40202

Industry:
Internist
Phone:
(502) 852-5757 (Phone)
Kenneth Robert Mcleish

Professional information

Kenneth Mcleish Photo 1

Dr. Kenneth Mcleish - MD (Doctor of Medicine)

Hospitals:
UofL Physicians - Kidney Disease Program
401 E Chestnut St SUITE 690, Louisville 40202
Jewish Hospital
200 Abraham Flexner Way, Louisville 40202
Norton Hospital
200 East Chestnut St, Louisville 40202
University of Louisville Hospital
530 South Jackson St, Louisville 40202
UofL Physicians - Kidney Disease Program
401 E Chestnut St SUITE 690, Louisville 40202
Jewish Hospital
200 Abraham Flexner Way, Louisville 40202
Norton Hospital
200 East Chestnut St, Louisville 40202
University of Louisville Hospital
530 South Jackson St, Louisville 40202
Philosophy:
At University of Louisville Physicians, we are committed to the delivering the very finest health care to our patients and their families and serving them with personalized care and compassion. As professors and researchers at the UofL School of Medicine, we offer our patients innovative technologies, state of the art treatments and the opportunity to be a part of world-renowned health care advancements.
Education:
Medical Schools
Indiana University School Of Medicine
Graduated: 1972


Kenneth Mcleish Photo 2

Professor At University Of Louisville Physicians

Position:
Professor at University of Louisville Physicians
Location:
Louisville, Kentucky Area
Industry:
Hospital & Health Care
Work:
University of Louisville Physicians - Professor


Kenneth R Mcleish Photo 3

Kenneth R McLeish, Louisville KY

Specialties:
Nephrologist
Address:
615 S Preston St, Louisville, KY 40202
Education:
Indiana University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)


Kenneth R Mcleish Photo 4

Kenneth R McLeish, Louisville KY

Specialties:
Internal Medicine, Nephrology
Work:
Robley Rex VA Medical Center
800 Zorn Ave, Louisville, KY 40206 University Medical Assoc
233 E Gray St, Louisville, KY 40202
Education:
Indiana University(1972)


Kenneth Mcleish Photo 5

Methods And Compositions For Inhibition Of Neutrophil Exocytosis

US Patent:
2011017, Jul 21, 2011
Filed:
Jul 28, 2009
Appl. No.:
13/056521
Inventors:
Kenneth R. McLeish - Louisville KY, US
Silvia M. Uriarte - Louisville KY, US
Madhavi J. Rane - Prospect KY, US
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
A61K 38/17, C07K 19/00, C07H 21/00, C07H 21/04, C12N 15/63, C12N 5/10, C12N 5/00, C12N 5/078, A61P 11/00, A61P 29/00, A61P 13/12, A61P 19/02, A61P 25/00
US Classification:
514 154, 530324, 530396, 536 234, 4353201, 435325, 435419, 435243, 435375, 514 213, 514 166, 514 177
Abstract:
Isolated fusion polypeptides are provided that are comprised of a cell-penetrating polypeptide and a SNARE polypeptide aptamer. Further provided are methods for inhibiting neutrophil granule exocytosis that comprise contacting a neutrophil with a fusion polypeptide including a cell-penetrating polypeptide and a SNARE polypeptide aptamer such that the fusion polypeptide enters the neutrophil and inhibits neutrophil granule exocytosis. Also provided are methods for treating a neutrophil-mediated inflammatory disorder by inhibiting SNARE-associated exocytosis in neutrophils.